Do we understand the electrophysiologic mechanisms responsible for drug-induced cardiac arrhythmias?

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 5, 2002, Pages 647-650

  Vos, Marc A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOKALANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; DOG; DRUG INDUCED DISEASE; EDITORIAL; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART REPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; SINUS RHYTHM; SODIUM CALCIUM EXCHANGE; TORSADE DES POINTES;

ANESTHETICS; ANIMALS; DOGS; ELECTROPHYSIOLOGY; HUMANS; MODELS, BIOLOGICAL; TORSADES DE POINTES;

EID: 0036872334     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200211000-00001     Document Type: Editorial

References (36)

1. Weissenburger J, Davy JM, Chezalviel F, et al. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: Comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. J Pharmacol Exp Ther 1991;259:871-83.
2. Vos MA, Verduyn SC, Gorgels AP, et al. Reproducible induction of early afterdepolarization and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 1995;91: 864-72.
3. Chezalviel-Guilbert F, Davy JM, Poirier JM, et al. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes. J Am Coll Cardiol 1995;26:787-92.
4. Chezalviel-Guilbert F, Weissenburger J, Davy JM, et al. Proarrhythmic effects of a quinidine analog in dogs with chronic A-V block. Fundam Clin Pharmacol 1995;9: 240-7.
5. Verduyn SC, Vos MA, van der Zande J, et al. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: A comparison between almokalant and d-sotalol using the dog as its own control. J Am Coll Cardiol 1997;30: 1575-84.
6. Verduyn SC, Vos MA, van der Zande J, et al. Role of interventricular dispersion of repolarization in acquired torsade de pointes arrhythmias: Reversal by magnesium. Cardiovasc Res 1997;34:453-63.
7. Chezalviel-Guilbert F, Deplanne V, Davy JM, et al. Combination of sotalol and quinidine in a canine model of torsades de pointes: No increase in the QT-related proarrhythmic action of sotalol. J Cardiovasc Electrophysiol 1998;9:498-507.
8. Vos MA, de Groot SH, Verduyn SC, et al. Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 1998;98:1125-35.
9. Freigang KD, Voss F, Becker R, et al. Polymorphic ventricular tachycardias induced by type-antiarrhythmic agents in dogs with chronic AV-block: Evidence for focal and reentrant mechanisms. PACE 1998;21:852.
10. Chen YJ, Hsieh MH, Chiou CW, et al. Electropharmacologic characteristics of ventricular proarrhythmia induced by ibutilide. J Cardiovasc Pharmacol 1999:34:237-47.
11. Chiba K, Sugiyama A, Satoh Y, et al. Proarrhythmic effects of fluoroquinolone antibacterial agents: In vivo effects as physiologic substrate for torsades. Toxicol Appl Pharmacol 2000;169:8-16.
12. Verduyn S, van Opstal J, Leunissen J, et al. Assessment of the antiarrhythmic potential of antiarrhythmic drugs: An experimental approach. J Cardiovasc Pharmacol Ther 2001;6:89-97.
13. Van Opstal JM, Leunissen JD, Wellens HJ, et al. Azimilide and dofetilide produce similar electrophysiological and pro-arrhythmic effects in a canine model of Torsade de Pointes arrhythmias. Eur J Pharmacol 2001;412:67-76.
14. Van Opstal JM, Verduyn SC, Leunissen HDM, et al. Electrophysiological parameters indicative of sudden cardiac death in the dog with chronic complete AV block. Cardiovasc Res 2001;50:354-61.
15. Vos MA, van Opstal JM, Leunissen JDM, et al. Electrophysiologic parameters and predisposing factors in the generation of drug-induced Torsade de Pointes arrhythmias. Pharmacol Ther 2001;92:109-22.
16. van Opstal JM, Schoenmakers M, Verduyn SC, et al. Chronic amiodarone evokes no Torsade de Pointes arrhythmias despite QT lengthening in an animal model of acquired long QT syndrome. Circulation 2001;104: 2722-7.
17. Volders PG, Sipido KR, Vos MA, et al. Downregulation of the delayed rectifier K+ current in dogs with chronic AV-block. Circulation 1999;100:2455-61.
18. Sipido KR, Volders PG, de Groot SH, et al. Enhanced calcium release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: A potential link between contractile adaptations and arrhythmogenesis. Circulation 2000;102;2137-44.
19. Kozhevnikov DO, Yamamoto K, Robotis D, et al. Electrophysiological mechanism of enhanced susceptibility of hypertrophied heart to acquired Torsade de Pointes arrhythmias: Tridimensional mapping of activation and recovery patterns. Circulation 2002;105:1128-34.
20. Voss F, Schreiner KD, Senges JC, et al. Refractory patterns and susceptibility to drug-induced polymorphic ventricular tachycardias in dogs with chronic atrioventricular block: Relationship to the type of anaesthesia. J Cardiovasc Pharmacol 2002;40:651-9.
21. Duker GD, Linhardt GS. An animal model for studying class III induced proarrhythmias in the halothane-anesthetized dog [abstract]. J Am Coll Cardiol 1994:326A.
22. Weissenburger J, Nesterenko VV, Antzelevitch C. Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: Torsades de pointes develops with halothane but not pentobarbital anesthesia. J Cardiovasc Electrophysiol 2000;11:290-304.
23. Yamamoto K, Tamura T, Imai R, et al. Acute canine model for drug induced Torsade de Pointes in drug safety evaluation: Influences of anaesthesia and validation with quinidine and astemizole. Toxicol Sci 2001;60:165-76.
24. Anyukovsky EP, Sosunov EA, Gainullin RZ, et al. The controversial M cell. J Cardiovasc Electrophysiol 1999; 10:1297-9.
25. Antzelevitch C, Shimizu W, Yan GX, et al. The M cell: Its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 1999;10:1124-52.
26. Franz MR. Letter to the editor. J Cardiovasc Electrophysiol 2000;11:946.
27. Jungschleger JG, Vos MA. Letter to the editor. J Cardiovasc Electrophysiol 2000;11:946-8.
28. Taggert P, Sutton PMI, Opthof T, et al. Transmural repolarization in the left ventricle in humans during normoxia and ischaemia. Cardiovasc Res 2001;50:454-62.
29. Antzelevitch C. Transmural dispersion of repolarization and the T wave. Cardiovasc Res 2001;50:426-31.
30. Vos MA, Jungschleger JGM. Transmural repolarization gradients in vivo: The flukes and falls of the endocardium. Cardiovasc Res 2001;50:423-5.
31. Haws CW, Lux RL. Correlation between in vivo transmembrane action potential durations and activation recovery intervals from electrograms: Effects of interventions that alter repolarization times. Circulation 1991;81:281-8.
32. El-Sherif N, Caref EB, Yin H, et al. The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome: Tridimensional mapping of activation and recovery patterns. Circ Res 1996;79:474-92.
33. Jungschleger JG, Leunissen HDM, van der Hulst FF, et al. Enhancement of left ventricular transmural dispersion after creation and persistence of AV-block in the dog. North American Society of Pacing and Electrophysiology, Boston, PACE Pacing Clin Electrophysiol 2001;24:624.
34. Senges JC, Sterns LD, Freigang KD, et al. Cesium chloride induced ventricular arrhythmias in dogs: Three-dimensional activation patterns and their relation to the cesium dose applied. Basic Res Cardiol 2000;95:152-62.
35. Murakawa Y, Sezaki K, Yamashita T, et al. Three-dimensional activation sequence of cesium-induced ventricular arrhythmias. Am J Physiol 1997;273(3 part 2): H1377-85.
36. Jungschleger JGM, van der Hulst F, Leunissen JDM, et al. No dominant role for re-entry in the perpetuation of drug induced Torsade de Pointes arrhythmias in the CAVB-dog. North American Society of Pacing and Electrophysiology, San Diego. PACE Pacing Clin Electrophysiol 2002; 25:627.